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This paper develops and applies an empirical framework to managing and measuring the 
longevity risk using derivative instruments, with the aim of suppressing the normal difficulties 
present in pricing the premium of this type of instruments. More precisely is developed a 
longevity swap using United States and Japan mortality data, creating a flexible and versatile 
approach for pricing swap instruments through the risk neutral simulation method. This 
method is calculated by forecasting survival probabilities, which were estimated and 
simulated by predicting the mortality parameters applying log bilinear Lee-Carter model 
across 60 years of both countries data (1954-2014). Using this approach and both countries 
empirical data is offered a comparative analysis across genders, different type of ages and risk 
levels. This way it’s possible to expand and test the previous literature contributions and flaws, 
proving that derivatives are a way to manage the longevity risk in large quantities, which 
should be considered by insurance companies. 
 




Esta dissertação desenvolve e, empiricamente, aplica uma abordagem recente para cobrir e 
calcular o risco de longevidade, através de instrumentos derivados. Têm o propósito de 
suprimir as dificuldades existentes para calcular o valor do prémio deste tipo de instrumentos 
que usam como input dados relativos à longevidade. Mais precisamente é desenvolvido um 
swap de longevidade através de dados reais dos Estados Unidos da Améria e Japão. Desta 
forma, cria-se uma abordagem flexível e versátil para calcular o valor de um swap através da 
risk-neutral simulation. Este método é aplicado através da estimação das probabilidades de 
sobrevivência, as quais são calculadas pela predição dos parâmetros de mortalidade usando 
o modelo Lee-Carter oisson. Esta técnica é realizada através de dados empíricos  de ambos os 
países, compreendida entre 1954-2014, permitindo uma análise comparativa entre géneros, 
diferentes idades e níveis de risco. Desta forma, expande-se o contributo da literatura prévia, 
demonstrando como instrumentos derivados podem auxiliar a gestão de risco de empresas 
seguradoras, aproveitando a capacidade de absorção do risco por parte do mercado de 
capitais. 
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Financial theory characterizes the risk by the dispersion of expected results on a certain 
investment, in consequence of movements in the financial variables (risk factors). The 
financial risk is multidimensional and, therefore, in recent years, risk management had an 
ample advance. One of the risks that have grown a lot is longevity risk. We can define longevity 
risk as the uncertainty on projections of longevity and massive amounts of liabilities exposed 
to this risk (Blake et al., 2006) or simply the risk that life spans exceed expectation, resulting 
in individual mortality rates lower than expected (Coughlan et al., 2011). 
Longevity risk can be distinguished into different dimensions as Blake et al. (p.506, 2013) 
mentioned: (i) micro-longevity risk or non-systematic risk; (ii) macro-longevity risk or 
systematic risk. Macro-longevity risk refers to the longevity risk in a huge group of people, 
such as members of a large pension plan or the annuitants in the annuity book of a large 
insurer. On macro-longevity risk, the trend risk is an example of a systematic or aggregative 
risk. The micro-longevity risk is the opposite, deals with the longevity risk in a small group of 
individuals, such as those underlying a life settlement fund, for example, an investment on 
individual life assurance policies.  In this paper, the main concept will be macro-longevity risk, 
since this is the most critical dimension of the global economy and the sustainability of 
insurance sector. 
The noticeable growth of scientific research about longevity risk and how to model it is 
flagrant in the last decades, partly due to the embryonic work of Lee and Carter (1992).  The 
fact that longevity risk has become a major focus of scientific research is explained by several 
reasons, one of them is its importance in developed societies. The longevity caused by the 
considerable changes in the lives and welfare of the developed countries took substantial 
fluctuations on the demographic transitions and had profound effects on the size, age, and 
structure of the world population. In developed countries, before 1900, the world population 
growth was slow, the age structure remained practically constant and relatively few people 
lived beyond 65 years. During the first half of the twentieth century, they began to draw up 
new rates of life expectancy, together with population growth. During the second half of the 
twentieth century this scenario has changed: fertility rates declined to almost half causing the 
slowdown in population growth, the percentage of young people in age pyramids began to 
lose to the older players, and aging population began to be a reality, increasingly apparent 
and sharp (Batini, Callen & McKibbin, 2006). Demographic changes reached all countries of 
the world not only developed countries, although these countries unfold at different rates. 
The economic and financial impact of demographic transitions is highlighted in Batini, Callen 
& Mckibbin (2006), where the percentage differences in the growth of countries would be 
between 30% to 60% lower. Differences in demographic transitions and the singularities of 
their indicators allow investors to understand the longevity risk, observe the movement of the 
indicators in the various angles of the world, to understand and predict potential longevity 
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shocks over time and uncover new forms and products to cover them (Creighton, Jin, Piggott, 
& Valdez, 2005; Nakada et al., 2014). 
However, the impact of global demographic changes, particularly those that took place in 
most developed countries, has brought new challenges to the insurance sector, its 
sustainability, as well as challenges to the economy itself. These difficulties are also a reason 
for the increasing scientific contribution in this area. Boyer and Stentoft (2013, pp. 35) 
mentioned that “(…)the longevity affected the overall profitability of institutions that offer 
lifetime pensions, such as large corporations and governments, as well the total savings of the 
individuals”. This happened because the insurance companies could not turn the mortality 
probability profitable enough through the large numbers rule, due the exponential increase 
of life expectancy in all the corners of the world.  
According to Dowd et al. (2006) if people live longer than anticipated, insurance companies 
make losses on their annuity books; and if people die sooner than projected, companies make 
losses on their life books. Due to this, it is important that insurance companies keep an 
appropriate reserve level to cover such eventualities, always preserving their solvency. The 
problem with this approach is that capital is costly and, given the difficulties of forecasting 
mortality rates over even short time horizons, it is hard to determine what adequate capital 
levels might be. Due to these situations, the insurance and reinsurance market (the traditional 
markets used to trade longevity risk products) have become insufficient, not because this type 
of risk was not manageable for insurance companies, but, due the exponential increase of life 
expectancy, longevity became difficult to commercialize through profitable products for 
insurance companies (even with reinsurers) and low-cost level for consumers. While the 
insurance sector was facing difficult challenges to manage longevity risk, the derivatives 
markets were growing exponentially to hedging the various types of risks. This growth of 
derivatives has become another reason that pushed longevity risk research forward, taking 
into consideration the potentialities and possible combinations between two separate 
“worlds” – insurance traditional life risk and capital markets instruments. 
The academic community, considering the size of the risk exposure, pointed the only way to 
potentially manage longevity risk by drawing upon the wealth of the entire capital market 
(Boyer and Stentoft, 2013). Then this solution came in 2008 when the world saw the first 
capital markets solutions for longevity risk, in a deal between Lucida ple and Canada Life in 
the United Kingdom (Coughlan et al., 2011). These two transactions made possible the 
development of the longevity risk transfer market, bringing additional capacity, flexibility, and 
transparency to complement existing insurance solutions that were insufficient. According to 
Boyer and Stentoft (2013 p.36), “The ability of capital markets to absorb larger amounts of 
risk than the market for life reinsurance stems from two factors: (i) first, capital markets are 
huge and much greater than the market capitalization and surplus of the insurance industry; 
(ii) second, there is virtually no correlation between longevity risk and market risk so that 
exposure to longevity risk shifts the portfolio frontier up and to the left”. 
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However, the development of capital market solutions for longevity risk has been too slow. 
Despite the capacity of financial markets to absorb this type of risk, some instruments have 
many challenges on the calculation of their fair values. The main challenges are: (i) first, 
mortality is not a traded asset and therefore we cannot value longevity products using non-
arbitrage principles, since we cannot build a replication portfolio; (ii) second, given that the 
cash flows of these products are directly linked to mortality or survival rates, their valuation 
requires the ability to forecast these rates accurately (Boyer and Stentof, 2013 p.36). On the 
other hand, the economic relevance/global exposure of the insurance sector is too high to let 
this system collapse. It is thus necessary to develop new techniques for computing the fair 
value of capital markets solutions to longevity risk to answer the demands of collective needs, 
since the number of institutions is “short” longevity, i.e., their liabilities increase if longevity 
increases. 
Taking into consideration the importance of longevity risk in developed societies, the 
insufficiency of insurance sector solutions to absorb this risk and the capital market 
potentiality’s, the goal of this paper is to price a Longevity Swap using the risk-neutral 
simulation approach developed by Boyer and Stentoft (2013), assuming the dynamics of 
mortality rates is modelled using log bilinear Lee-Carter model under a Poisson setting, and 
the risk-neutral distribution of the innovations is obtained using the Wang transform.    
Taking this goal into account, in this paper we forecast the force of mortality using the log-
bilinear Lee-Carter model under a Poisson setting to compare the survival probabilities of the 
female and male populations of the USA and Japan. We then compute longevity Swap 
premiums (taking into consideration both, USA and Japan data, for the different genders and 
ages) applying a risk-neutral simulated method for pricing. 
This paper contributes to the growing literature debate on the need for manage longevity/ 
mortality risk in the insurance and pension fund industries. This will be done through two 
different ways, the first one is the claim that cross-country capital markets can absorb the 
longevity risk, being a profitable tool; and the second, is in demonstrating that swaps can be 
an effective hedging and trading instrument for the major risks in the XXI century, surpassing 
the difficulties of their fair value calculations.  To answer this main goal, the paper is split into 
three logical sections; the first section makes a review of the research done regarding capital 
markets solutions to hedge longevity risk, with more detail on longevity swaps. The second 
section describes the methodology of risk-neutral simulation and how this method will be 
applied in this paper. Finally, we conduct an empirical investigation on how to price the 
longevity vanilla swap using USA and Japan data (exploring female and male mortality data in 
separate scenarios) using the risk neutral simulation approach. 
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2. LONGEVITY RISK SOLUTIONS: TRADITIONAL AND DERIVATIVES PRODUCTS 
Longevity risk is the risk that life spans exceed expectation, resulting in individual mortality 
rates lower than expected. This type of risk is one of the most relevant risks to the economy, 
due to the importance and the consequences of longevity in our days. Longevity becomes a 
key concept discussed in the XXI century, due to the multiple demographic changes felt in 
almost all the countries of the world (developed and developing countries). The technological 
revolution at medical, agriculture and industrial levels allowed populations to live longer than 
anticipated and challenging the economic sustainability every day. One example of the current 
challenges faced by insurance companies is the difficulty in profiting from traditional longevity 
insurance products due to both longevity and interest rate risks. Due to these incapacities, 
derivatives become the key focus for hedging longevity risk. Below, we describe how longevity 
could be hedge with traditional and derivatives products through a brief literature review. 
 
2.1 LONGEVITY TRADITIONAL PRODUCTS 
Until the XXI century longevity risk was hedged by insurance companies through conventional 
and conservative methods. The traditional solutions to hedge this type of risk had itself an 
evolution, from basic methods to “advanced” forms.  
Blake, Cairns & Dowd (2006) claim that insurance companies started to respond to longevity 
risk by simply accepting the risk as part of their core business, which they understand well and 
are used to manage. After, they began to share longevity risk across distinct types of products, 
socio-economic groups and countries, this way they could balance their portfolios by seeking 
to exploit the conceivable natural hedges involved running a mixed business of term assurance 
and annuity.  
However, since longevity became difficult to hedge due its significant exposure, insurance 
companies required another type of guarantee to make this risk manageable and sustainable. 
Due to this, the various forms of reinsure with a reinsuring company have become the answer 
to hedge longevity, since those contracts allowed sharing some, or all, of the downside of 
longevity risk with the reinsurer. 
Besides reinsurance, pension plans allowed arrange for a bulk buyout of their pensions in 
payment, passing on the responsibility for payment to an insurance company, permitted risk 
sharing as reinsurance contracts. Similarly, smaller pension plans are accustomed to 
purchasing annuities at the time of retirement for each plan member. This hedges the total 
risk in their pool of pensioners. Unless the plan purchases deferred pensions on a regular basis, 
it still bears the longevity risk for current active members and deferred pensioners between 
now and their retirement dates (by Blake, Cairns & Dowd, 2006). 
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Insurance companies which are annuity providers might choose to replace the traditional non-
participating annuities for participating contracts. These contracts allow passing part of the 
exposure to longevity risk to the surviving participating policyholders, this way the companies 
can hedge the risk more easily, since those products that pay bonuses or survival credits to 
annuitants that can take account of experienced mortality rates within the pool of annuitants. 
Nonetheless, since the cost of reinsurance is high, pensions and annuity provided only applied 
it to a limited extent, the securitization on mortality starting to appear - since the need to 
trade longevity risk at a low cost was a priority (Cowley & Cummins, 2005). 
The traditional longevity risk solutions described above began collapsing due to their 
insufficiencies to address the risk at low hedging costs on a large group of people that live 
longer than expected. As a result, insurance companies and pension plans started to manage 
longevity risk using mortality-linked securities on traded contacts such as longevity bonds, 
annuity futures, forwards, index-based instruments and, finally, swaps and options. These 
institutions began transferring risk to the only entity that can manage these exposure 
amounts: capital market (Dowd et al., 2006). The capital market was and still is, the only 
solution to respond to a significant number of collective needs of the users, suppressing the 
short number and the capacity of the institutions that trade/manage mortality risk.  Below we 
describe these new instruments. 
 
2.2 LONGEVITY DERIVATIVE PRODUCTS 
The derivative products for longevity emerged as an obvious solution to trade and deal with 
higher amounts of exposures, crushing the advantages of the traditional solutions to manage 
longevity or mortality risk.  Derivatives for longevity were launched in different generations/ 
steps of time.  Fung et al. (2005) classified the capital markets solutions for longevity risk in 
three different generations: (i) the first generation was based on longevity/survival bonds; (ii) 
followed by q-forwards, survival/mortality futures and survival/mortality swaps on second 
stage; (ii) and finally, longevity/survival options. These securities have the usual features we 
would expect to find in bonds, swaps, futures and options. 
As mentioned by Blake, Cairns & Dowd (2006), there is an important distinction between those 
that are traded over-the-counter markets (OTC) (e.g. swaps), and those that are traded on 
organised exchanges (e.g. futures); and those who have a linear payoff with the one's with 
non-linear payoff. The former has the attraction that they can be tailor-made to the 
requirements of a user (which keeps down basis risk), but have the disadvantage that they 
have thin secondary markets (which makes positions harder to unwind); the latter has the 
attraction of greater market liquidity (which facilitates unwinding), but have the disadvantage 
of increased basis risk.  
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The first generation of capital market solutions was based on bonds, longevity bonds, the most 
basic instrument to hedge the risk (Blake & Burrows, 2001; Blake et al., 2006a; Bauer et 
al.,2010; Fung et. all, 2015).  In the literature, we found different types of bonds that trade 
longevity. Blake, Cairns & Dowd (2006) distinguish two main types of bonds: (i) the first are 
“principal-at-risk” longevity bonds (longevity bonds in which the investor risks losing all or part 
of the principal if the relevant mortality event occurs); (ii) the second are “coupon-based” 
longevity bonds (these are bonds in which the coupon-payment is mortality-dependent). The 
nature of this dependence can also vary: the payment might be a smooth function of a 
mortality index, or it might be specified in ‘at risk’ terms, i.e. the investor loses some or the 
entire coupon if the mortality index crosses some threshold. Coupon-based bonds are 
distinguished in many types: (i) the classical longevity bonds; (ii) the zero-coupon bonds, the 
(iii) deferred longevity bonds and (iv) other kinds.  Besides these two categories, we can also 
have an array of more complex hybrid longevity bonds. 
The “principal-at-risk” longevity bond became popular through the Swiss Re mortality bond in 
2003. This bond helped to reduce Swiss Re's exposure to a catastrophic mortality 
deterioration. The structure of this bond is simple, as explained in Blake et al. (2006). The bond 
is issued by a single pension plan or annuity provider (A) using a special purpose vehicle (SPV). 
At the outset, the SPV is funded by contributions from A and external investors (B). The total 
outgo of the SPV would mimic either a floating-rate or a fixed interest bond paying annual 
coupons and with a final repayment of principal at maturity. Under normal circumstances 
coupons and principal would be payable in full to B. However, if a designated survival index, 
S(t), exceeds a specified threshold then a reduction in the repayment of principal to B (and 
possibly also the coupons) would be triggered, with the residual payable to A Blake, Cairns & 
Dowd, 2006). 
On the other hand, the “coupon-based” longevity bond become popular trough EIB/ BNPP 
transaction. This bond commercialized with the European Investment Bank (EIB) in 2004, 
which was underwritten by BNP Paribas – as the designer and originator and Partner Re as the 
longevity risk reinsurer. The face value of the issue was £540 million, and the bond had a 25-
year maturity. The bond was an annuity (or amortizing) bond with floating coupon payments, 
and its innovative feature was to link the coupon payments to a cohort survival index based 
on the realized mortality rates of English and Welsh males aged 65 in 2002. This bond worked 
like a classic longevity bond (Blake et al., 2006). 
However, although an innovation, this bond generation had limited success, wasn’t well 
received by investors, and couldn’t generate enough demand to be launched due to its 
deficiencies, but was crucial to present the longevity products on capital markets due the 
public attention received.  
Like the first generation, the second involved linear payoff instruments, but in this time most 
complex contracts were used: forwards, futures and swaps. Q-forwards launched this 
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generation, the mortality hedge was provided by J.P Morgan, and was novel not just because 
it involved a longevity index and a new kind of product, but also because it was a hedge of 
value rather than a hedge of cash payments. The importance of q-forwards rests on the fact 
that they form basic blocks from which other, complex, life-related derivatives can be 
constructed. When appropriately designed, a portfolio of q-forwards can be used to replicate 
and to hedge the longevity exposure of an annuity or a pension liability or to hedge the 
mortality exposures of a life assurance book. 
As mentioned by Black et al. (2003), a q-forward is similar to a forward contract, however, 
uses mortality as an asset. It is defined as an agreement between two parties in which they 
agree to exchange an amount proportional to the actual, realized mortality rate of a given 
population (or subpopulation) in return for an amount proportional to a fixed mortality rate 
that has been mutually agreed at inception to be payable at a future date (the maturity of the 
contract). In this sense, a q-forward is a swap that exchanges fixed mortality for the realized 
mortality at maturity. As for the other derivative products, the variable used to settle the 
contract is the realized mortality rate for the reference population in a future period. In short 
hedging longevity risk in a pension plan, using a q-forward the pension plan will receive the 
fixed mortality rate and pay the realized mortality rate (and hence locks in the future mortality 
rate it should pay whatever happens to actual rates). The counterparty to this transaction, 
typically an investment bank, has the different exposure, paying the fixed mortality rates, and 
receiving the realized rate.  
Due to q-forward success, another type of contracts started to be envisaged: futures and 
swaps. Futures on longevity are very like the q-forwards, instruments to hedge longevity risk. 
However, this type of contracts is more inflexible than q-forwards, since the last ones are 
customized (Barrieu, Veraart, 2014; LIMA, 2010a).  In short, the basic form of a futures 
contract involves defining the underlying (typically price) process, S(t), that will define the 
payoff in the future, and the delivery date, T, of the futures contract, mortality futures follow 
this logic (Blake, Cairns & Dowd, 2006). Many studies showed the potentialities of futures 
markets (see Gray, 1978, Ederington, 1979, Carlton, 1984, Black, 1986, Pierog & Stein,1989, 
Corkish, Holland & Vila, 1997 and Brorsen & Fofana, 2001). However, mortality futures had 
and still have, some difficulties in establishing a longevity market. If a liquid market in longevity 
bonds develops in time, then it might be possible for a futures market to develop which uses 
the price or prices of longevity bonds as the underlying (Blake, Cairns & Dowd, 2006). 
Contrary to futures, longevity swap contracts became a considerable success story. The first 
longevity swap transaction was recorded by J.P. Morgan in July 2008, with Canada Life in the 
United Kingdom (Blacke et al., 2013). It was a 40-year maturity £500 million longevity swap 
that was linked not to an index, but to the actual mortality experience of the 125.000-plus 
annuitants in the annuity portfolio that was being hedged. It also differed in being a cash flow 
hedge of longevity risk. But, most significantly, this transaction brought capital markets 
investors into the Life Market for the very first time, as the longevity risk was passed from 
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Canada Life to J.P. Morgan and then directly on to investors. This has become the archetypal 
longevity swap upon which other transactions are based (Blake et al., 2013).  
A longevity swap is as an instrument that involves exchanging actual pension payments for a 
series of pre-agreed fixed payments. Each payment is based on an amount-weighed survival 
rate. After this transaction, longevity swaps (or survival swaps) became a big focus on capital 
markets solutions to hedge longevity risk, due to its multiple advantages.  This second 
generation caught much more attraction from investors due to its ability to manage 
appropriately systematic mortality risk, particularly index-based longevity swaps that can be 
traded as standardized contracts, and due to their lower hedging costs. 
Finally, the last generation of capital markets instruments solutions is based on options, non-
linear payoff instruments. As claimed by Blake, Cairns & Dowd (2006), it's possible to have a 
lot of assorted products in this generation, such as (i) survival caps; (ii) survival floors; (iii) 
annuity futures options; (iv) OTC options and embedded options; and more complex products 
such as (v) mortality swaptions. Non-linear derivatives for longevity risk are still a solution not 
well explored and accepted by investors, due to the inherent risks that they carry (Fung et al., 
2015; Bayer et al., 2010).  
The focus of this article is on second generation instruments, due the growing attention in 
these products. More specifically, longevity swaps will be the derivative product use to show 
an effective tool to hedge longevity risk. In the sub-section below we will present in more 
detail the longevity swaps as well as ways to price this tool. 
 
2.2.1 LONGEVITY/SURVIVAL SWAPS 
 
As mentioned in the previous section, longevity swaps are one of considerable success of 
capital markets second generation solutions, due to their attractive intrinsic characteristics. 
The first mortality swap showed in the market was the one embedded in the EIB bond, 
mentioned in the section above.  A swap for mortality issues has some advantages when 
compared with others capital markets solutions. Like referred by Blake et al., (2006, p.19), 
swaps can be arranged at lower transactions cost than a bond and are more easily cancelled. 
They are more flexible than other solutions and can be tailor-made to suit diverse 
circumstances. They do not require the existence of a liquid market, just the willingness of 
counterparties to exploit their comparative advantages or trade views on the development of 
mortality over time. A swap also has advantages over traditional insurance arrangements: 
they involve lower transactions costs and are more flexible than reinsurance treaties, due to 
the fact of that instruments aren’t insurance contracts in the legal sense of the term, so aren’t 
affected by legal features like indemnity, insurable interest etc. Instead are subjective 
instruments, in terms of requirements of securities law, so it is allowed to speculate on a 
random variable and does not required the policyholder to have an insurable interest.  
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Because of these advantages, it's known from industry contracts that some insurance 
companies have already entered mortality or longevity swaps on OTC (over-the-counter) 
basis. The counterparties are usually life companies, and some investment banks are also 
interested in swap transactions. The attractions of these agreements are obvious ones of risk 
mitigation and capital release for those laying off longevity risk, and low-beta risk exposures 
for those taking it on (Blake, Cairns & Dowd, 2006, p.20).  
As Cox & Lin (2004) explained, a mortality swap can also be used to help firms that run both 
annuity and life books to manage the natural hedges implicit in their positions. The type of 
swap, in this case, might be a floating- for-floating swap, with one floating leg tied to the 
annuity provider's annuity payments and the other to the life assurer's insurance pay-outs 
(Blake et al., 2006). Swaps can also be used as vehicles to speculate on longevity risk, so it’s a 
type of contract that pleases all parties in the capital markets. 
Despite its advantages, a swap is a risk management tool and is therefore subject to certain 
kinds of risk.  The main risk that one longevity swap can have for the buyers is counterparty 
risk. This is a major problem with most swaps because swaps can entail significant exposures 
to counterparty credit risk. One straightforward way to upgrade these respective counterparty 
risks is for the swap to specify that payments are to be made on a net rather than gross basis, 
which is why existing swaps routinely specify net payment (Dowd et al., 2006). Achieving 
further reductions in counterparty exposure is more difficult, but such problems are common 
to OTC derivatives trades, and the standard methods of dealing with them in OTC derivatives 
markets could also be used to handle counterparty credit issues in survival or longevity swaps 
markets as well, like mentioned by Dowd et al. (2006) special purpose vehicles, credit 
insurance and credit derivatives and credit enhancement. 
In the literature, the longevity and survival swaps are addressed by diverse authors, especially, 
by Dawson (2002),  Blake (2003), Dowd (2003), Dawson (2006), Blake et al., (2006) and Lin and 
Cox (2005). In terms of definitions, mortality-linked swaps are divided into two distinct types, 
depending on the underlying asset: (i) Mortality Swaps or (ii) Longevity/Survival Swaps. Both 
instruments originated in capital markets to hedge longevity risk, however, although they 
have similar characteristics, each one provides a hedge for different risk factor: mortality 
(demise early than expected) or longevity (live longer than anticipated). In this paper, our 
focus will be longevity/survival swaps as defined by Dowd et al. (2006). 
Besides this basic distinction, a swap can have diverse types: (i) it can be a standardized hedge, 
or a (ii) customized hedge. As Blake et al. (2013) described, a standardized index-based 
longevity swap hedges have some advantages over the customized hedges in terms of 
simplicity, cost and liquidity. But they also have obvious disadvantages, principally the fact 
that they are not perfect hedges and leave a residual basis risk that requires the index hedge 
to be carefully calibrated. Contrary, customized hedges are custom-made, so they’ have an 
exact hedge (so no residual basis risk’s), however, are poor in liquidity, expensive and have 
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longer maturities than the standardized (more counterparty credit exposure) so are less 
attractive to investors. 
In the most basic case, a swap, for distinct types of hedges (customized or standardized) and 
underlying asset (mortality or longevity), are defined as an agreement by which two parties 
agree to exchange one or more future cash flows, at least one of which is random (Dowd et 
al., 2006). Taking into consideration a definition of swap, one longevity swap could be defined 
as an agreement to exchange one or more cash flows in the future based on the outcome of 
at least one (random) longevity-dependent payment (Blake et al., 2006 p.19).  
A variety of swaps that trade longevity/mortality as an underlying asset can be found in 
scientific papers, from the most basic forms like (i) one-payment mortality (or survival) swaps; 
(ii) vanilla mortality (or survival) swaps, up to other more complex forms like: (i) swaps on 
mortality spreads; (ii) cross-currency mortality swaps; (iii) mortality swaps in which one or 
more floating payment depends on a non-mortality random variable (for example an interest 
rate, a stock index, etc.); and (iv) mortality swaps with embedded features such as options 
(Blake, Cairns & Dowd, 2006 p.21).  
One-payment mortality (or survival) swap is the most basic form of swaps on longevity and 
mortality business, involve exchange, at time 0, of a single payment K(t), for a single random 
mortality-dependent payment S(t) at some future time t (Blake et al., 2006 p.19). On the other 
hand, the vanilla survival or longevity swap is a swap in which the parties agree to swap a 
series of payments periodically (i.e., for every t = 1, 2, . . . , T) until the swap matures in period 
T (Dowd et al. 2006). This type of swap is reminiscent of a vanilla interest-rate swap (IRS), 
which involves one fixed leg and one floating leg typically related to a market rate such as 
LIBOR/EURIBOR. However, like mentioned by Dowd (2006 p.4), there are several key 
differences: (i) the fixed leg of the IRS specifies payments that are constant over time, whereas 
the corresponding leg of the Vanilla Survivor Swaps (VSS) involves present payments that 
decline over time in line with the survival index anticipated at time 0; (ii) also, the floating leg 
of the IRS is tied to a market interest rate, whereas the floating leg of the VSS depends on the 
realized value of the survival index at time t; (iii) finally, the IRS can be valued using a zero-
arbitrage condition because of the existence of a liquid bond market. 
This is not the case with a VSS which must be valued in incomplete markets setting. Besides 
these two types, we could have swaps that involve the exchange of one floating-rate payment 
for another or more elaborate types of swap: swaps on mortality spreads, cross-currency 
mortality swaps, mortality swaps in which one or more floating payment depends on a non-
mortality random variable (an interest rate, a stock index, etc.), and mortality swaps with 
embedded features such as options (Blake et al., 2006 p.21).  
The swaps described above discussed and developed by various authors like Dawson (2002),  
Blake (2003), Dowd (2003), Dowd et al. (2006), Blake et al., (2006), Cox and Lin (2004) and Lin 
and Cox (2005).  In addition to the notable contributions in terms of definition and structure 
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of longevity and mortality swaps by Blake et al. (2006; 2013; 2003) and Dowd et al. 
(2006;2003) in their vast portfolio of articles, Lin and Cox (2004;2005) had one of the most 
significant contributions to the subject. These two authors present survival/longevity swaps 
as ideal instruments for managing, hedging, and trading mortality-dependent risks, and they 
offer many benefits to insurance companies that need to manage such risks, besides that, they 
show how swaps can be priced, and provide a thorough analysis of how insurance companies 
might use them to exploit natural hedge opportunities across their annuity and life businesses. 
In this paper we will be using a vanilla longevity swap to hedge the longevity risk for USA and 
Japan. Like Boyer and Stentoft (2003), on this vanilla longevity swap, the premium of this swap 
is one simple portfolio of q-forwards, since a q-forward is the easiest instrument which can be 
used to hedge the exposures to longevity risk at a given moment, and but extension a portfolio 
of such forwards can be used to hedge the risk over a period. This type of instrument is well 
known in the market for interest rate risk where the combined portfolio is traded together as 
an interest rate swap. So, similarly a survival or longevity swap is the simplest one portfolio of 
q-forwards. To better understand how this type of swap works let’s analyse the q-forwards 
math. Following Boyer and Stentoft (2003), to illustrate how a q-forward works let  Sx,t 
e  be the 
expected probability that an individual aged x survives from time t-1 to time t, give the 
information currently available. Similarly, let Sx,t 
r  be the realized percentage of individuals 
aged x that survive from time t-1 to time 1. Knowing that a forward premium today is then 
fixed such that: 




And defined the adjustment factor πft  of this q-forward as the solution to: 
 (1 + 𝜋𝑡 
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)𝑁𝑃𝑉 (𝑆𝑥,𝑡 









Besides the fixed amount being dependent on the expected survival rate, these are 















Where the result is the price of the q-forward at this moment. When we have a contract with 
different maturities, for example, the premium for one q-forward contract on the survival 












Knowing the price of a q-forward, it’s easier to understand the price of one longevity swap 
since it’s a simple portfolio of q-forwards. For example, we could consider a swap on the 
survival rates from t−1 to t, from t to t + 1, and from t + 1 to t + 2. The straightforward 
generalization of the formula for the q-forward price formula showed yields the following 




𝑟 ) +  𝑁𝑃𝑉 (𝑆𝑥,𝑡+1 
𝑟 ) +  𝑁𝑃𝑉 (𝑆𝑥,𝑡+2 
𝑟 )
𝑁𝑃𝑉 (𝑆𝑥,𝑡+1 
𝑒 ) +  𝑁𝑃𝑉 (𝑆𝑥,𝑡+1+1 





Thus, the net payment to a long position in this swap, at time t, is given by the expression 
below, where these payments are realized until the end of the contract: 
𝑆𝑥,𝑡  
𝑟 − (1 +  𝜋𝑡,𝑡+2




In this article, we’ll consider the mortality of different ages across the time and structure 
longevity derivatives directly on a given survival probabilities.  
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2. HOW TO PRICE DERIVATIVES USING SIMULATION  
3.1. NEUTRAL RISK DISTRIBUTIONS 
In literature, alternative approaches for pricing longevity-linked derivatives have been 
presented. These instruments require the ability to forecast future mortality rates. Some 
studies use mortality projection models, such as extrapolation models. However, we can be 
pricing derivatives follow a derivative pricing perspective, using risk-neutral simulation 
technique.  
Boyer and Stentoft (2013) showed how risk-neutral distributions and risk-neutral simulation 
could be used to evaluate derivate products, such as forwards, swaps and options. In this 
paper, we’ll follow this methodology since it is a type of approach which surpasses some 
difficulties to evaluate the derivatives based on mortality (the reason that has in part delayed 
the development of this market). 
In longevity-derivative products, mortality or longevity are traded like another type of 
underlying asset. However, mortality or longevity are not continuously traded assets and as 
such, this market is to be considered incomplete and a risk premium exists for the exposure 
to this type of risky asset (Boyer and Stentoft, 2013). Wang (2000) and Boyer and Stentoft, 
2013) showed how to evaluate a financial asset basing on a distortion of the cumulative 
distribution of a variable X. This yields a new risk-adjusted cumulative distribution of cash 
flows that can then be discounted at the risk-free rate. Wang (2000) defines the following risk-
adjusted distribution:  




•  𝐹 ̃(𝑥) is the cumulative distribution function of variable X 
• Φ is the normal cumulative distribution function 
• 𝜆  is a risk premium 
With the Wang-distortion above, it is possible to price derivatives easily, since this method 
can be applied to any type of distribution function F (x) and can be adjusted to account for the 
uncertainty (the risk) that surrounds the distribution parameters.  This distortion retains the 
so desirable normal and Log-Normal distributions. So, if X follows a Normal distribution with 
 N (μ, σ2) then the transformed variable X̃  also follows a normal distribution with N (μ −
 λσ, σ2); following the same thought, if X follows a Log- Normal distribution with  
ln(X)~ N (μ, σ2), then the transformed variable X̃  also follows a Log-Normal distribution with 





3.2. RISK NEUTRAL SIMULATION 
Using the Wang-distortion above, it is possible distort the final distribution including the risk 
premium (λ), which adjust the calculations due to the risk and allows to obtain the price of 
the swap contract. To apply this method, it is necessary to adjust the risk directly to the 
simulation, by the method used through Boyer and Stentoft (2013) research, the risk neutral 
simulation approach. The risk neutral simulation has an immediate benefit since all paths have 
equal probability to occur. This method is applied thought the property of the Normal and 
Log-Normal models mentioned in previous section. In particular, since the distortion retains 
the Normal and Log-Normal distributions, an obvious alternative to the method of risk 
adjusting the distribution is to simulate directly the risk adjusted innovations. In a Normal 
model for example, we simulate directly with innovations that are ϵ~ N(− λσ, σ2) instead a 
ϵ~ N(0, σ2) and then distorting the distribution according the risk (Boyer and Stentoft, 2013).  
 
3.3. STOCHASTIC MODELING AND CALIBRATION: MORTALITY PARAMETERS AND 
PROBABILITIES CALCULATION 
As mentioned above, the biggest problem in pricing longevity derivatives are mortality rates, 
since they are very difficult to predict. For forecasting futures mortality rates, various 
stochastic models have been developed.  The first contribution to a prediction of dynamic 
mortality was a proposal by Blaschke (1923) who introduced a version based on Makeham's 
law. However, only later, with the work of Lee & Carter (1992), we have made significant 
progress in the stochastic modelling of mortality. Using the central mortality rates of the 
United States of America, the authors presented an extrapolation model that allows, in a 
simple way, to describe a mortality of the population using a single time trend parameter, 
projected using time series methods. 
Other authors also sought to introduce improvements in the formulation of Lee-Carter, 
especially Wilmoth (1993), Alho (2000), Brouhns et al. (2002) and Renshaw & Haberman 
(2006), that introduced some improvements on Lee-Carter model using a log-bilinear Poisson 
regression to estimate the parameters, instead of using the principal components 
decomposition method (which presents problems of homoscedasticity). Renshaw & 
Haberman (2008) provide an extension of the Lee-Carter model that allows for the inclusion 
of cohort effects, that is, it is a year of birth. Years later, Cairns et al. (2006) introduced a similar 
model called CBD (Cairns-Blake-Dowd), which contains two stochastic factors to represent the 
mortality dynamics. 
In this article, we’ll provide results for the case when the dynamic of mortality rates is 
modelled using the log-bilinear Lee-Carter model under a Poisson setting. To better 
understand this model we’ll describe briefly the Lee-Carter-Poisson model used.  
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The log-bilinear Poisson Lee-Carter model assumes the following: 
𝐷𝑥,𝑡 ~ 𝑃𝑜𝑖𝑠𝑠𝑜𝑛 (𝜇𝑥(𝑡)𝐸𝑥,𝑡) 𝑤𝑖𝑡ℎ 𝜇𝑥(𝑡) =  𝑒





• 𝜇𝑥(𝑡) is the observed force of mortality at age 𝑥 during the year t; 
• 𝐷𝑥,𝑡 is the number of deaths recorded at age 𝑥 during the year t, from those 
exposed-to-risk 𝐸𝑥,𝑡 
• 𝛼𝑥 denotes the general shape of the mortality schedule 
• 𝛽𝑥 represents the age-specific patterns of mortality change 
• 𝑘𝑡 represents the time trend 
 
To forecast the mortality rates, we calibrate this model to the USA and Japan population (male 
and female), using data from 1954 to 2014 and ages 50-100 for estimation. Data on deaths 
and risk exposures are obtained from the Human Mortality Database. The parameter 
estimates are obtained using Linear Models and an interactive method for estimation log-
bilinear as Goodman (1979). Goodman iterative process takes advantage of the Newton-
Raphson algorithm to estimate the mortality parameters with log-bilinear parameters. In 
general terms, this iterative process involves using, in each iteration (v + 1),  a set of 
parameters θ = (θ1, θ2, … . , θn),   while the other parameters remain fixed, using: 
 











To implement this algorithm, we follow Brouhns et al. (2002) steps to estimate the mortality 
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After 1000 iterations we normalize the parameters to fulfil the Lee-Carter constraints: 
 
?̂?  ← 𝛼?̂? +  𝛽?̂? ?̅? 
𝑘?̂?  ← (𝑘?̂? −  ?̅? ) ∑ 𝛽?̂? 







In the figures below it’s possible to see the distributions of this parameter for EUA and Japan 
data (female and male): 
 
 





Figure 2 – Mortality estimator’s distribution based on USA’s male data 
 
 
Figure 3 – Mortality estimator’s distribution based on Japan’s female data 
 
 
Figure 4 – Mortality estimator’s distribution based on Japan’s male data 
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In this model, vectors αx  and βx remain constant over time and we forecast futures values of 
𝑘𝑡 using a standard univariate time series model such as the classic random walk with ARIMA 
(0,1,0) defined as: 
𝑘𝑡 =  𝜃 + 𝑘𝑡−1 + 𝜖𝑡  , 𝜖𝑡 ~𝑁(0, 𝜎
2) 
(12) 
where the drift 𝜃 and the volatility 𝜎 are estimated from our data. 
  
Table 1 - Parameter estimates and goodness-of-fit measures for ARIMA(0,1,0) model using data for 
US and Japan from 1954 to 2014. 
 𝜽 s.e 𝜽 𝝈𝟐 AIC BIC 
US Female -0.456819 0.0927076 0.559687 139.7075 141.8184 
US Male -0.442613 0.085826 0.425968 123.0537 125.1646 
Japan Female -1.10225 0.183781 2.24954 224.5647 226.6755 
Japan Male -0.781281 0.167581 1.78297 210.3856 212.4965 
 
The uncertainty about future mortality rates is a consequence of the uncertainty about the 
future values of 𝑘𝑡 as this depends critically on the innovations. For pricing, we consider the 
market price of longevity risk. Following the risk neutral simulation approach this is done by 
risk-neutralizing the innovations using the Wang distortion operator described above (Wang, 
2000; Boyer and Stentoft, 2013).  
So, taking advantage of the Wang-transform methodology benefits, instead of using random 
draws for the ϵt from a ϵ~ N(0, σ
2) distribution we use draws from a ϵ~ N(− λσ, σ2) 
distributions, as mentioned in (12).   This allows for straightforward pricing of the swap 
contract. Our simulation consists of N =10000 trajectories of 𝑘𝑡, to generate recursively, one 
of each year necessary to price the longevity derivatives, and a random Normal error, 
considering a given value for the risk premium parameter λ.  In our simulations, we’ll use risk 
premium parameter between 0.0 and 0.3, range defined for Lin and Cox with reasonable 
estimations. In the figures below, it is possible see kt final values for each country and gender, 
considering λ = 0.0. 
 
Figure 5 - 𝑘𝑡 parameter estimates for USA data per gender and year 
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Figure 7 - 𝜇𝑥(𝑡) values for each country and gender, per year. 
 
 
Figure 6 - 𝑘𝑡 parameter estimates for Japan data per gender and year 
 
After all parameter estimates have been calculated, we can obtain μx(t) for each country and 
gender (in the figure below it is possible see this data considering λ = 0.0) and compare if the 
























When mortality force (μx) have been calculated the survival probability (px) was obtained 
through the below transformation 
𝑝𝑥,𝑡 =  𝑒
− 𝜇𝑥,𝑡 (13) 
The figure below shows the survival probability for both countries and genders. As literature 
showed across the years, the survival probability is higher for females in both countries. 
However, Japan has the higher survival probability in both genders, when comparing with US 
data. 
 
Figure 8 Survival Probabilities (𝑝𝑥,𝑡)for USA and Japan data 
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3. PRICING LONGEVITY SWAP CONTRACTS: AN EMPIRICAL 
INVESTIGATION 
To compute the longevity swap premium we followed the equation below, where the survival 
probabilities calculated was used as the floating leg of the contract, and (NPV (Sx,t 
r )), and the 
fix leg was the mean of the calculated survival probability (NPV (Sx,t 
e ). We calculated the swap 
premiums for both genders in both countries to compare how the different genders and 
cultures can impact on the swap price. Beside this, we analyse the pice for different ages at 
initiation (65,75 and 85) and reported such simulated risk neutral density means for the years 
2010-2014 and for different Wang transform's risk premium levels (λ =  0.1,0.2,0.3). This way 
we can analyse how the age and risk premium impact on the swap price. The notional amount 
used for all types of swaps is 100,000€ and a fixed risk-free rate of 3% for discounting future 
cash flows. The yield curve used was calculated using USA treasury department data base. The 




𝑟 ) +  𝑁𝑃𝑉 (𝑆𝑥,𝑡+1 
𝑟 ) +  𝑁𝑃𝑉 (𝑆𝑥,𝑡+2 
𝑟 ) + 𝑁𝑃𝑉 (𝑆𝑥,𝑡+3
𝑟 ) + 𝑁𝑃𝑉 (𝑆𝑥,𝑡+4 
𝑟 )
𝑁𝑃𝑉 (𝑆𝑥,𝑡+1 
𝑒 ) +  𝑁𝑃𝑉 (𝑆𝑥,𝑡+1+1 
𝑒 ) +  𝑁𝑃𝑉 (𝑆𝑥,𝑡+2 
𝑒 ) + 𝑁𝑃𝑉 (𝑆𝑥,𝑡+3 





Taking into consideration the information above, longevity swap premium calculation in the 
next section its presented for both genders, by country: (i) Female results for US and Japan 
data; and (ii) Male figures for US and Japan data. Please note that for both testes a sensitive 
analysis is done across different ages and risks levels.  
3.1. TEST I – SWAP PRICING USING SURVIVAL PROBABILITIES THROUGH THE 
SIMULATED MEAN: FEMALE 
Using the formula presented in (14), in the first test run, it is possible to calculate the longevity 
swap premiums, which are feed by female US and female Japan predicted survival 
probabilities (through formula 13). The results in basis points are present for US (table 1) and 
Japan (table 2), where it is possible to check the premiums for 1 to 5 years of maturity 
contracts, different ages (65, 75 and 85) and alternative longevity risk premium levels. 
Analysing the premiums value from tables 2 and 3, applying a macro perspective, it is possible 
to check that, as the maturity increases there is an increase in the premium value, having both 
the same growth tendency. The same is true for the risk premium level, since as the risk rises 
the value of swap premiums accompanies this growth. Also, it’s possible to verify that the 
premium values are not identical for all ages, since for 65 years the swap premium value 
registers a smaller amount when compared to that of a contract designed for and individuals 
aged 85 years old at initiation. These tendencies follow an expected survival framework and 
are observable in both countries, since when the age increase the survival probability will be 
lower and the amount requested to cover that event would be higher. The same is applied for 
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the risk premium level and maturity, since when the risk and maturity are higher the investor 
should have a better return and the swap is more valuable. 
The macro patterns are equal for both countries. However, exploring the values in detail it is 
possible to detect a few differences. In comparing US and Japan values it is noticeable that 
Japan premiums are slightly lower than US counterparts. This difference could be explained 
by the fact that survival probabilities are higher in Japan (check figure 8, when it is possible to 
see those differences visually).  
Table 2 – Longevity Swap prices for different maturities and longevity risk premium levels using US 
Female data (2010-2014) 
x=65 1 2 3 4 5 
𝜆 =  0.1 0.0801 0.1483 0.9042 1.5991 1.6626 
𝜆 =  0.2 0.0837 0.1529 0.9119 1.6098 1.6778 
𝜆 =  0.3 0.0872 0.1574 0.9193 1.6197 1.6918 
x=75 1 2 3 4 5 
λ= 0.1 0.1876 0.5602 0.9693 1.6877 2.7873 
λ= 0.2 0.1876 0.5606 0.9692 1.6876 2.7874 
𝜆 =  0.3 0.1872 0.5629 0.9688 1.6871 2.7864 
x=85 1 2 3 4 5 
λ= 0.1 0.8602 1.2178 2.0286 3.7557 4.8830 
λ= 0.2 0.9104 1.2234 2.1915 3.7686 4.9012 
λ= 0.3 1.9925 2.2175 3.0120 5.7458 6.8688 
 
Table 3 – Longevity Swap prices for different maturities and longevity risk premium levels using 
Japan Female data (2010-2014) 
x=65 1 2 3 4 5 
𝜆 =  0.1 0.0854 0.1315 0.8744 1.5552 1.6019 
𝜆 =  0.2 0.0891 0.1464 0.8986 1.5914 1.6476 
𝜆 =  0.3 0.1007 0.1513 0.9106 1.6093 1.6785 
x=75 1 2 3 4 5 
λ= 0.1 0.1918 0.5362 0.9774 1.6983 2.8023 
λ= 0.2 0.1901 0.5363 0.9734 1.6930 2.7949 
𝜆 =  0.3 0.1903 0.5257 0.9741 1.6939 2.7954 
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x=85 1 2 3 4 5 
λ= 0.1 0.8505 1.2322 2.0433 3.7864 4.9276 
λ= 0.2 0.9578 1.2336 2.0442 3.7877 4.9291 
λ= 0.3 1.1971 2.2375 3.0197 5.7573 6.8799 
 
3.2. TEST II – SWAP PRICING USING SURVIVAL PROBABILITIES THROUGH THE 
SIMULATED MEAN: MALE 
After testing female data, we calculated the longevity swap premiums based on male data, for 
both countries. The results in basis points are presented for US (table 4) and Japan (table 5), 
where we depict the premiums values for the different maturity, ages and longevity risk 
premium levels, as was done for female data.  
Analysing the premiums value from tables 4 and 5 it is possible to verify that, as observed in 
female data, the maturity has a positive effect in the swap premium since, for all ages, the 
premium value is higher for longer maturities. Beside this effect, the age at contract initiation 
still has a key role in this framework, since as expected when the age increases the swap 
premium value increases too. The higher swap premium is registered for 5 year contracts 
based on 85 year old individuals at contract initiation in both countries. This relationship 
between age and maturity is accompanied by the longevity risk premium effect. The risk, as 
exposed in female results, has an increase effect in premium values, across all ages and 
maturities. As in female results, these tendencies follow an expectancy survival framework 
and are observable in both countries, including a micro analysis, due the fact of US male data 
register higher premiums than Japan male date.  
 
Table 4- Swap Premiums for different maturities and risk using US Male data (2010-2014) 
 
x=65 1 2 3 4 5 
𝜆 =  0.1 0.0827 0.1444 0.8977 1.5900 2.6498 
𝜆 =  0.2 0.0864 0.1494 0.9060 1.6014 2.6659 
𝜆 =  0.3 0.0904 0.1540 0.9137 1.6119 2.6807 
x=75 1 2 3 4 5 
λ= 0.1 0.1886 0.5523 0.9710 1.6901 2.7909 
λ= 0.2 0.1884 0.5537 0.9707 1.6897 2.7903 
𝜆 =  0.3 0.1882 0.5557 0.9703 1.6891 2.7895 
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x=85 1 2 3 4 5 
λ= 0.1 1.2399 2.2177 3.0193 4.7560 4.9159 
λ= 0.2 1.2820 2.2226 3.0273 4.7670 5.8991 
λ= 0.3 1.3207 2.2279 3.0361 4.7789 6.8836 
 
 
 Table 5 - Swap Premiums for different maturities and risk using Japan Male data (2010-2014) 
x=65 1 2 3 4 5 
𝜆 =  0.1 0.0878 0.1329 0.8821 1.5683 2.6205 
𝜆 =  0.2 0.0924 0.1428 0.8966 1.5907 2.6519 
𝜆 =  0.3 0.0990 0.1493 0.9072 1.6029 2.6675 
x=75 1 2 3 4 5 
λ= 0.1 0.1897 0.5211 0.9731 1.6930 2.7943 
λ= 0.2 0.1907 0.5343 0.9746 1.6949 2.7967 
𝜆 =  0.3 0.1926 0.5414 0.9775 1.6987 2.8036 
x=85 1 2 3 4 5 
λ= 0.1 1.1314 2.2281 3.0346 4.0805 5.9083 
λ= 0.2 1.1619 2.2368 3.0510 4.2774 5.9359 
λ= 0.3 1.2353 2.2422 3.0599 4.7976 6.9458 
 
3.3. SENSITIVITY ANALYSIS: AGES, RISK AND GENDERS 
The results presented above showed a few macro tendencies, however its feasible comparing 
female and male data directly and verify the advantages and disadvantages of both results. In 
this section we conduct a sensitivity analysis to the results provided above by considering and 
comparing female and male scenarios for ages 65 and 85 and two types of risk level.  
In figure 9 we exhibit the results for male and female data for 65 and 85 years, using 0.1 as 
our longevity risk premium. The first observable conclusion is that for 65 years the female 
premiums are between 0 and 2 and for the male premiums they range between 0-3, so a slight 
difference exists. This tendency is still observed when we use the 85-year old reference cohort. 
Due to this, is possible to verify that, independent of the age used as reference, the effect of 
the risk premium level in swap prices is the same.  
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However, male data is significantly different from female data since, as the figure 9 shows, the 
female values are smoothed, and the main tendency still the same for the two ages and 
maturities. In other ways, male data shows a different effect. The effect in male premiums for 
85 years old is different than 65 old years, since for 65 years we’ve a smoothed behavior and, 
nonetheless, for 85 years the US male data registers a higher value for all maturities, excluding 
for 5-year contracts for which Japan contracts are more expensive than US equivalent 
contracts.   Beside this effect, when comparing directly male data with female it is possible to 
notice that the swap premium values for the 65-year old female cohort tends to stabilize 
between maturities 4 and 6, while male premiums continue to increase in a proportional way. 
For 85 years old the behavior is different, since for females we’re having a proportional 
increase in both countries, and for males while US data suffers a stabilization Japan data still 
increase proportionally.   
 
 
Figure 9 – Female and Male premiums for 65 and 85 ages and risk level 0.1 
 
After testing and reporting the comparison between male and female data for a risk level of 
0.1, was tested the same data for a risk level 0.3. The results are reported in figure 10. In this 
figure it is possible to verify that the risk level affects all results (for male, female 65 and 85 
years old contracts) in the same way, since all premiums value increase significantly.  Due to 
this, as confirmed above, the level of risk affects all data in the same way.  
Comparing with the previous scenario both data (US and Japan) register a smooth behavior. 
Analyzing 65-year old contracts results it is possible to verify that female data increase with 
the maturity, however, there is an inclination to stabilize between maturities 4 and 5, while 
male data increase in a direct way for all maturities. For higher reference ages the premiums 
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performance is also identical for both genders and countries: an increase. While for lower risk 
level the performance was slightly different.  
Please note that for all scenarios US data has the higher premiums when comparing directly 
with Japan, and independently of the sex considered (excluding for 85 years old with λ= 0.1) .  
 
 

















In our days, longevity is a reality in developed and developing countries. Insurers and 
reinsurers around the world find themselves in a fragile condition to cover this risk efficiently 
and profitably. Considering this need, this paper aims to demonstrate how derivatives, typical 
of financial markets, can be used to manage longevity, overcoming the problem of calculating 
their premium and fair value.  
Taking this goal into account, it was possible to calculate some longevity swap premiums, for 
different scenarios, by forecasting the force of mortality, (assuming the dynamics of mortality) 
and by using log bilinear Lee-Carter model under a Poisson setting, and estimated survival 
probabilities using US and Japan, after transforming this adding the risk through the Wang 
transform and risk-neutral simulated technique. With this technique we could simulate 
different longevity swap premiums for 65, 75 and 85 years old and for both genders using US 
and Japan data. Across this analysis, it was noticeable that the risk level and maturity have a 
positive effect in premium values, increase them independent of the age or gender used. Was 
notorious that premium values for male data are higher than female, independent of the years 
old used as reference. For different years old we obtained a different result, higher for higher 
ages and lower for lower ages.  These tendencies follow an expectancy survival framework, 
and are observable in both countries, since when the age increase the survival probability will 
be lower and the amount requested to cover that event would be higher. The same is applied 
for the risk level and maturity, since when the risk and maturity is higher the investor should 
have a better return and the swap is more valuable.  
The market for longevity remains a poorly exploited market for its absorption by financial 
markets, and this article makes a significant contribution to the aid calculating its premiums 
and fair values. For further investigation, it is recommended to apply this approach to more 
derivative instruments, for example options, and using different type of input data, such as 
survival or mortality index. Given the simplicity of this methodology, it enables a series of 
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Age 𝛼?̂? 𝛽?̂? Year 𝑘?̂? 
 
Age 𝛼?̂? 𝛽?̂? Year 𝑘?̂? 
50 -5.4926 0.024136 1954 14.08191 
 
50 -4.90924 0.025016 1954 10.02211 
51 -5.4158 0.022681 1955 12.67283 
 
51 -4.82486 0.024718 1955 9.73891 
52 -5.32236 0.023521 1956 12.49995 
 
52 -4.7291 0.025587 1956 9.08726 
53 -5.25079 0.02339 1957 12.32581 
 
53 -4.65204 0.025598 1957 8.762114 
54 -5.17689 0.023438 1958 11.97483 
 
54 -4.57146 0.026463 1958 8.011376 
55 -5.09838 0.022403 1959 10.71317 
 
55 -4.48037 0.025973 1959 7.115701 
56 -5.01437 0.02233 1960 10.26216 
 
56 -4.40207 0.026309 1960 5.717481 
57 -4.93733 0.022029 1961 9.607001 
 
57 -4.32145 0.026737 1961 5.270342 
58 -4.83871 0.022263 1962 10.00394 
 
58 -4.22318 0.027087 1962 4.556328 
59 -4.7662 0.022782 1963 9.536823 
 
59 -4.15048 0.027914 1963 3.86626 
60 -4.66636 0.023369 1964 9.327274 
 
60 -4.05158 0.028472 1964 3.346671 
61 -4.59169 0.022052 1965 8.581054 
 
61 -3.98274 0.028249 1965 2.043833 
62 -4.48134 0.02377 1966 7.80449 
 
62 -3.87979 0.029271 1966 1.201193 
63 -4.41284 0.02281 1967 7.646994 
 
63 -3.81194 0.029101 1967 0.881338 
64 -4.33745 0.022522 1968 6.192192 
 
64 -3.73767 0.028952 1968 0.461946 
65 -4.23587 0.024047 1969 4.888829 
 
65 -3.64807 0.029985 1969 -0.66579 
66 -4.17064 0.022301 1970 3.680986 
 
66 -3.58379 0.02852 1970 -1.78371 
67 -4.0786 0.023151 1971 2.844767 
 
67 -3.50222 0.028984 1971 -2.98712 
68 -3.99125 0.022994 1972 2.700605 
 
68 -3.42126 0.028099 1972 -4.65519 
69 -3.91077 0.022365 1973 2.497155 
 
69 -3.34774 0.026997 1973 -5.37621 
70 -3.79874 0.023697 1974 0.947919 
 
70 -3.25218 0.027413 1974 -5.84406 
71 -3.72863 0.021879 1975 0.123793 
 
71 -3.18685 0.025804 1975 -6.23049 
72 -3.60899 0.024301 1976 -0.51973 
 
72 -3.0879 0.026819 1976 -6.83555 
73 -3.52359 0.023998 1977 -1.31857 
 
73 -3.01349 0.025519 1977 -7.99911 
74 -3.43281 0.024899 1978 -1.77376 
 
74 -2.93343 0.025579 1978 -8.49417 
75 -3.32663 0.026186 1979 -2.27229 
 
75 -2.84599 0.025196 1979 -9.6195 
76 -3.23754 0.025462 1980 -3.26002 
 
76 -2.76837 0.024261 1980 -10.7292 
77 -3.14758 0.024823 1981 -4.03764 
 
77 -2.68846 0.023085 1981 -11.9169 
78 -3.04461 0.026036 1982 -5.92637 
 
78 -2.60782 0.022467 1982 -13.0116 
79 -2.94123 0.025903 1983 -5.40653 
 
79 -2.52091 0.021974 1983 -14.0594 
80 -2.82031 0.025015 1984 -6.62812 
 
80 -2.4071 0.021518 1984 -15.0621 
81 -2.73609 0.022776 1985 -8.00725 
 
81 -2.33071 0.019626 1985 -15.9027 
82 -2.61754 0.023379 1986 -8.87067 
 
82 -2.23354 0.019385 1986 -16.7446 
83 -2.50764 0.023583 1987 -10.0267 
 
83 -2.14098 0.018915 1987 -17.7155 
84 -2.39924 0.023088 1988 -10.7225 
 
84 -2.04915 0.018174 1988 -18.6398 
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85 -2.29469 0.022172 1989 -11.6354 
 
85 -1.96333 0.017128 1989 -18.7491 
86 -2.18848 0.021148 1990 -11.387 
 
86 -1.87272 0.01604 1990 -19.1602 
87 -2.08572 0.020028 1991 -11.2806 
 
87 -1.78652 0.015028 1991 -19.7389 
88 -1.99075 0.018237 1992 -12.8683 
 
88 -1.70665 0.013373 1992 -20.7601 
89 -1.88702 0.016927 1993 -13.1931 
 
89 -1.61691 0.012395 1993 -21.739 
90 -1.77757 0.016296 1994 -14.2189 
 
90 -1.53099 0.010895 1994 -22.9836 
91 -1.70105 0.012733 1995 -15.0091 
 
91 -1.46175 0.008599 1995 -23.0408 
92 -1.5955 0.011968 1996 -15.623 
 
92 -1.37017 0.007481 1996 -23.4475 
93 -1.49966 0.010816 1997 -15.421 
 
93 -1.28527 0.006207 1997 -24.024 
94 -1.40875 0.009198 1998 -16.2185 
 
94 -1.2121 0.004441 1998 -24.8695 
95 -1.32613 0.007397 1999 -15.7124 
 
95 -1.14365 0.003012 1999 -25.9208 
96 -1.24633 0.005721 2000 -16.6849 
 
96 -1.06707 0.00203 2000 -26.4263 
97 -1.16998 0.004258 2001 -17.0708 
 
97 -1.00605 0.00051 2001 -26.1041 
98 -1.10603 0.001866 2002 -17.5115 
 
98 -0.96117 -0.00155 2002 -27.1483 
99 -1.05747 -0.00057 2003 -18.1378 
 
99 -0.91508 -0.00364 2003 -28.0636 
100 -0.98033 -0.00157 2004 -18.5286 
 
100 -0.86011 -0.00571 2004 -28.8135    
2005 -18.969 
    
2005 -30.0681    
2006 -20.1666 
    
2006 -30.5024    
2007 -21.4835 
    
2007 -31.2461    
2008 -20.4213 
    
2008 -30.9831    
2009 -21.6342 
    
2009 -31.727    
2010 -23.3474 
    
2010 -32.2346    
2011 -23.9425 
    
2011 -33.3066    
2012 -23.9608 
    
2012 -34.0736    
2013 -24.3972 
    
2013 -35.1336    
2014 -25.5689 















Age 𝛼?̂? 𝛽?̂? Year 𝑘?̂? 
 
Age 𝛼?̂? 𝛽?̂? Year 𝑘?̂? 
50 -5.87362 0.019507 1954 33.97242 
 
50 -5.27251 0.021148 1954 23.85827 
51 -5.79039 0.019583 1955 29.4949 
 
51 -5.18423 0.020994 1955 23.16191 
52 -5.71483 0.019658 1956 29.98603 
 
52 -5.08797 0.020888 1956 21.75661 
53 -5.63487 0.019617 1957 30.47204 
 
53 -4.99666 0.020949 1957 20.38995 
54 -5.55841 0.01958 1958 30.2473 
 
54 -4.90765 0.021011 1958 19.95297 
55 -5.48701 0.019569 1959 26.36231 
 
55 -4.8122 0.021024 1959 20.09013 
56 -5.40609 0.019937 1960 25.73553 
 
56 -4.72305 0.021356 1960 18.2223 
57 -5.32905 0.020185 1961 24.28823 
 
57 -4.63246 0.021545 1961 17.78563 
58 -5.23408 0.021308 1962 27.0696 
 
58 -4.52971 0.022488 1962 16.22626 
59 -5.16119 0.020672 1963 26.37807 
 
59 -4.44485 0.022266 1963 16.83168 
60 -5.07442 0.020951 1964 26.72178 
 
60 -4.35686 0.02204 1964 17.37173 
61 -4.97921 0.021253 1965 24.90848 
 
61 -4.2636 0.022373 1965 15.02316 
62 -4.89352 0.021626 1966 22.97321 
 
62 -4.1686 0.022615 1966 14.35542 
63 -4.79735 0.022039 1967 23.52614 
 
63 -4.076 0.022754 1967 13.54379 
64 -4.69841 0.02247 1968 18.86484 
 
64 -3.98276 0.023215 1968 12.54432 
65 -4.60204 0.022609 1969 14.81223 
 
65 -3.89071 0.023533 1969 13.37028 
66 -4.50176 0.022934 1970 11.14353 
 
66 -3.79694 0.023802 1970 11.06749 
67 -4.39786 0.023534 1971 8.968491 
 
67 -3.70176 0.024299 1971 9.04212 
68 -4.28964 0.023834 1972 9.575018 
 
68 -3.60596 0.024618 1972 5.758271 
69 -4.17924 0.023911 1973 9.943248 
 
69 -3.50494 0.024543 1973 7.345973 
70 -4.06617 0.024086 1974 4.902399 
 
70 -3.40383 0.024881 1974 6.82976 
71 -3.95196 0.024251 1975 2.775963 
 
71 -3.30632 0.025137 1975 5.556071 
72 -3.83505 0.024321 1976 1.375425 
 
72 -3.20285 0.025022 1976 5.010074 
73 -3.71591 0.024319 1977 -0.64938 
 
73 -3.10281 0.02502 1977 4.028477 
74 -3.5983 0.02429 1978 -1.29297 
 
74 -2.99698 0.024889 1978 3.520704 
75 -3.47486 0.024118 1979 -2.11072 
 
75 -2.89344 0.02473 1979 2.535374 
76 -3.35088 0.023978 1980 -4.89476 
 
76 -2.79014 0.024177 1980 2.398247 
77 -3.22723 0.023598 1981 -6.83426 
 
77 -2.68225 0.02381 1981 1.316973 
78 -3.10376 0.023437 1982 -13.2396 
 
78 -2.57627 0.023397 1982 4.583869 
79 -2.97805 0.022971 1983 -9.9643 
 
79 -2.47188 0.022808 1983 2.017224 
80 -2.84913 0.022609 1984 -13.6882 
 
80 -2.36609 0.02223 1984 -1.3919 
81 -2.72338 0.022154 1985 -18.0454 
 
81 -2.26257 0.021558 1985 -4.7635 
82 -2.60415 0.02158 1986 -20.3298 
 
82 -2.16038 0.021086 1986 -8.66495 
83 -2.47886 0.021162 1987 -23.7904 
 
83 -2.06208 0.020486 1987 -10.2774 
84 -2.36004 0.020533 1988 -25.4007 
 
84 -1.96519 0.019551 1988 -11.6907 
85 -2.24106 0.019769 1989 -27.8839 
 
85 -1.86665 0.018948 1989 -13.484 
86 -2.12312 0.019321 1990 -25.6999 
 
86 -1.77134 0.018398 1990 -13.3864 
87 -2.00707 0.018507 1991 -24.0863 
 
87 -1.68217 0.017565 1991 -13.9865 
88 -1.8945 0.017806 1992 -29.2815 
 
88 -1.58952 0.01689 1992 -13.8393 
89 -1.78195 0.017142 1993 -29.4013 
 
89 -1.50299 0.016207 1993 -12.3514 
90 -1.67748 0.016217 1994 -32.338 
 
90 -1.41133 0.015503 1994 -10.1052 
91 -1.56703 0.015631 1995 -34.3281 
 
91 -1.33008 0.014656 1995 -12.839 
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92 -1.46859 0.014957 1996 -35.6097 
 
92 -1.24848 0.013955 1996 -15.9561 
93 -1.37655 0.014014 1997 -33.6117 
 
93 -1.1768 0.013001 1997 -16.2221 
94 -1.28131 0.013429 1998 -35.6311 
 
94 -1.10638 0.011577 1998 -19.7532 
95 -1.20359 0.012386 1999 -32.4113 
 
95 -1.03426 0.010598 1999 -20.8214 
96 -1.11608 0.011678 2000 -35.1338 
 
96 -0.9655 0.009612 2000 -21.8675 
97 -1.05066 0.010532 2001 -35.4992 
 
97 -0.9077 0.008112 2001 -21.1141 
98 -0.96911 0.009996 2002 -36.0845 
 
98 -0.85526 0.006385 2002 -22.3636 
99 -0.90657 0.009134 2003 -37.4157 
 
99 -0.79246 0.006184 2003 -24.0275 
100 -0.85041 0.007298 2004 -37.8005 
 
100 -0.71688 0.006166 2004 -24.4179    
2005 -38.3846 
    
2005 -24.4458    
2006 -42.012 
    
2006 -25.538    
2007 -46.1193 
    
2007 -27.4179    
2008 -40.6641 
    
2008 -30.4477    
2009 -44.3528 
    
2009 -31.2418    
2010 -50.0529 
    
2010 -33.559    
2011 -51.2586 
    
2011 -37.774    
2012 -50.1465 
    
2012 -37.7254    
2013 -50.7142 
    
2013 -40.1507    
2014 -54.2377 
    
2014 -41.5909 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
